Literature DB >> 25176133

Auto-inhibition at a ligand-gated ion channel: a cross-talk between orthosteric and allosteric sites.

Xiang-Qun Hu1.   

Abstract

BACKGROUND AND
PURPOSE: A ligand is believed to produce either positive or negative responses, or to block both of them. However, an indole compound was found to promote both positive and negative effects at the 5-HT3 AB receptor, which displays a low level of spontaneous activity. The present study attempted to delineate the mechanisms underlying this phenomenon. EXPERIMENTAL APPROACH: The spontaneously active V291S 5-HT3 A receptor was used to explore the properties of 5-hydroxyindole (5-HoI) and 5-methoxyindole (5-MoI), structural analogues of 5-HT, either alone or in combination with orthosteric probes. KEY
RESULTS: Two types of efficacy switching were initiated by altering ligand structure and concentration. At lower concentrations, a subtle structural change at position 5 of the indole molecule resulted in opposite effects. 5-HoI apparently elicited partial allosteric inverse agonism, whereas 5-MoI induced allosteric agonism. Interestingly, at a higher concentration, these indoles produced distinct auto-inhibition, manifested as a switch from positive to negative effects. 5-HoI induced a transition from orthosteric agonism to allosteric inverse agonism, whereas 5-MoI produced a shift from allosteric agonism to orthosteric inverse agonism. The auto-inhibition appears to involve communication between orthosteric and allosteric sites of the active receptor conformation and/or between inactive and active conformations. An additive effect of orthosteric and allosteric inverse agonism and insensitivity of allosteric agonism to orthosteric antagonism were also demonstrated. CONCLUSIONS AND IMPLICATIONS: Together, the results suggest that the moiety at position 5 of the indole structure is a critical determinant of a ligand's properties at the 5-HT3 A receptor, providing new insights into understanding ligand-receptor interactions.
© 2014 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25176133      PMCID: PMC4280970          DOI: 10.1111/bph.12896

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  45 in total

1.  5-HT3 receptors mediate serotonergic fast synaptic excitation of neocortical vasoactive intestinal peptide/cholecystokinin interneurons.

Authors:  Isabelle Férézou; Bruno Cauli; Elisa L Hill; Jean Rossier; Edith Hamel; Bertrand Lambolez
Journal:  J Neurosci       Date:  2002-09-01       Impact factor: 6.167

2.  Which agonist properties are important for the activation of 5-HT3A receptors?

Authors:  M F Meiboom; M Barann; S Witten; K Groeneveld; B W Urban
Journal:  Biochim Biophys Acta       Date:  2013-06-18

3.  Probing the role of a conserved M1 proline residue in 5-hydroxytryptamine(3) receptor gating.

Authors:  H Dang; P M England; S S Farivar; D A Dougherty; H A Lester
Journal:  Mol Pharmacol       Date:  2000-06       Impact factor: 4.436

Review 4.  Drugs for allosteric sites on receptors.

Authors:  Cody J Wenthur; Patrick R Gentry; Thomas P Mathews; Craig W Lindsley
Journal:  Annu Rev Pharmacol Toxicol       Date:  2013-10-02       Impact factor: 13.820

5.  Galantamine activates muscle-type nicotinic acetylcholine receptors without binding to the acetylcholine-binding site.

Authors:  Gustav Akk; Joe Henry Steinbach
Journal:  J Neurosci       Date:  2005-02-23       Impact factor: 6.167

6.  Role of aspartate 298 in mouse 5-HT3A receptor gating and modulation by extracellular Ca2+.

Authors:  Xiang-Qun Hu; David M Lovinger
Journal:  J Physiol       Date:  2005-08-11       Impact factor: 5.182

7.  Mechanism of action of benzodiazepines on GABAA receptors.

Authors:  Claudia Campo-Soria; Yongchang Chang; David S Weiss
Journal:  Br J Pharmacol       Date:  2006-06-19       Impact factor: 8.739

8.  Activation of α7 nicotinic receptors by orthosteric and allosteric agonists: influence on single-channel kinetics and conductance.

Authors:  Magda M Pałczyńska; Marie Jindrichova; Alasdair J Gibb; Neil S Millar
Journal:  Mol Pharmacol       Date:  2012-08-08       Impact factor: 4.436

9.  The Concise Guide to PHARMACOLOGY 2013/14: ligand-gated ion channels.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

10.  The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands.

Authors:  Adam J Pawson; Joanna L Sharman; Helen E Benson; Elena Faccenda; Stephen P H Alexander; O Peter Buneman; Anthony P Davenport; John C McGrath; John A Peters; Christopher Southan; Michael Spedding; Wenyuan Yu; Anthony J Harmar
Journal:  Nucleic Acids Res       Date:  2013-11-14       Impact factor: 16.971

View more
  1 in total

1.  Novel mechanism of modulation at a ligand-gated ion channel; action of 5-Cl-indole at the 5-HT3 A receptor.

Authors:  Andrew D Powell; Gillian Grafton; Alexander Roberts; Shannon Larkin; Nathanael O'Neill; Josephine Palandri; Reka Otvos; Alison J Cooper; Chris Ulens; Nicholas M Barnes
Journal:  Br J Pharmacol       Date:  2016-11-01       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.